14-3-3zeta cooperates with Phosphorylated Plk1 and is required for correct cytokinesis

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 2, 2012, Pages 639-650

  Du, Jian ^a   Chen, Lijian ^a   Luo, Xin ^a   Shen, Yuxian ^a   Dou, Zhen ^b   Shen, Jilong ^a   Cheng, Li ^a   Chen, Ying ^a   Li, Chengjin ^a   Wang, Hua ^c   Yao, Xuebiao ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Key Laboratory for Cellular Dynamics and Chemical Biology   (China)

^c ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

14 3 3; Phosphorylation; Plk1; Regulation of cytokinesis

Indexed keywords

14 3 3ZETA PROTEIN; CELL PROTEIN; ISOPROTEIN; POLO LIKE KINASE 1; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN 14 3 3; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINESIS; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HYBRID; IN VIVO STUDY; METAPHASE; MITOSIS; MUTANT; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; YEAST; METABOLISM; MITOSIS SPINDLE; PHOSPHORYLATION; PHYSIOLOGY; REVIEW;

EUKARYOTA;

14-3-3 PROTEINS; CELL CYCLE PROTEINS; CYTOKINESIS; HUMANS; MITOSIS; MITOTIC SPINDLE APPARATUS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 84869468679     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s290     Document Type: Article

References (39)

1. N. J. Ganem, Z. Storchova and D. Pellman: Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev, 17(2), 157-62 (2007) (Pubitemid 46551722)
2. D. M. Glover, I. M. Hagan and A. A. Tavares: Polo-like kinases: a team that plays throughout mitosis. Genes Dev, 12(24), 3777-87 (1998) (Pubitemid 29024839)
3. E. A. Nigg: Polo-like kinases: positive regulators of cell division from start to finish. Curr Opin Cell Biol, 10(6), 776-83 (1998) (Pubitemid 28561024)
4. F. A. Barr, H. H. Sillje and E. A. Nigg: Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol, 5(6), 429-40 (2004) (Pubitemid 38745493)
5. L. Arnaud, J. Pines and E. A. Nigg: GFP tagging reveals human Polo-like kinase 1 at the kinetochore/centromere region of mitotic chromosomes. Chromosoma, 107(6-7), 424-9 (1998) (Pubitemid 29057535)
6. I. M. Brennan, U. Peters, T. M. Kapoor and A. F. Straight: Polo-like kinase controls vertebrate spindle elongation and cytokinesis. PLoS One, 2(5), e409 (2007)
7. M. E. Burkard, C. L. Randall, S. Larochelle, C. Zhang, K. M. Shokat, R. P. Fisher and P. V. Jallepalli: Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proc Natl Acad Sci U S A, 104(11), 4383-8 (2007) (Pubitemid 47186235)
8. M. Petronczki, M. Glotzer, N. Kraut and J. M. Peters: Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle. Dev Cell, 12(5), 713-25 (2007) (Pubitemid 46667747)
9. A. Santamaria, R. Neef, U. Eberspacher, K. Eis, M. Husemann, D. Mumberg, S. Prechtl, V. Schulze, G. Siemeister, L. Wortmann, F. A. Barr and E. A. Nigg: Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis. Mol Biol Cell, 18(10), 4024-36 (2007) (Pubitemid 47519493)
10. H. Fu, R. R. Subramanian and S. C. Masters: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol, 40, 617-47 (2000) (Pubitemid 30340695)
11. M. J. van Hemert, H. Y. Steensma and G. P. van Heusden: 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays, 23(10), 936-46 (2001) (Pubitemid 32972693)
12. S. W. Jang, X. Liu, H. Fu, H. Rees, M. Yepes, A. Levey and K. Ye: Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J Biol Chem, 284(36), 24512-25 (2009)
13. G. Tzivion and J. Avruch: 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem, 277(5), 3061-4 (2002) (Pubitemid 34953163)
14. L. M. Cockrell, M. C. Puckett, E. H. Goldman, F. R. Khuri and H. Fu: Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome. Oncogene, 29(6), 822-30 (2010)
15. S. A. Maxwell, Z. Li, D. Jaye, S. Ballard, J. Ferrell and H. Fu: 14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. J Biol Chem, 284(33), 22379-89 (2009)
16. V. A. Smits and R. H. Medema: Checking out the G (2)/M transition. Biochim Biophys Acta, 1519(1-2), 1-12 (2001)
17. D. V. Bulavin, Y. Higashimoto, Z. N. Demidenko, S. Meek, P. Graves, C. Phillips, H. Zhao, S. A. Moody, E. Appella, H. Piwnica-Worms and A. J. Fornace, Jr.: Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol, 5(6), 545-51 (2003) (Pubitemid 36781089)
18. P. R. Graves, C. M. Lovly, G. L. Uy and H. Piwnica-Worms: Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene, 20(15), 1839-51 (2001) (Pubitemid 32458694)
19. A. Aitken: 14-3-3 proteins: a historic overview. Semin Cancer Biol, 16(3), 162-72 (2006) (Pubitemid 43796128)
20. H. Hermeking: The 14-3-3 cancer connection. Nat Rev Cancer, 3(12), 931-43 (2003) (Pubitemid 37500178)
21. E. W. Wilker, M. A. van Vugt, S. A. Artim, P. H. Huang, C. P. Petersen, H. C. Reinhardt, Y. Feng, P. A. Sharp, N. Sonenberg, F. M. White and M. B. Yaffe: 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature, 446(7133), 329-32 (2007) (Pubitemid 46426148)
22. T. Zhou, J. P. Aumais, X. Liu, L. Y. Yu-Lee and R. L. Erikson: A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell, 5(1), 127-38 (2003) (Pubitemid 36827347)
23. H. Martin, J. Rostas, Y. Patel and A. Aitken: Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem, 63(6), 2259-65 (1994) (Pubitemid 24370003)
24. M. J. van Hemert, M. Niemantsverdriet, T. Schmidt, C. Backendorf and H. P. Spaink: Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3 sigma and 14-3-3 zeta. J Cell Sci, 117(Pt 8), 1411-20 (2004) (Pubitemid 38559817)
25. A. J. Muslin and H. Xing: 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal, 12(11-12), 703-9 (2000) (Pubitemid 32056337)
26. C. Laronga, H. Y. Yang, C. Neal and M. H. Lee: Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem, 275(30), 23106-12 (2000) (Pubitemid 30646202)
27. M. B. Yaffe, K. Rittinger, S. Volinia, P. R. Caron, A. Aitken, H. Leffers, S. J. Gamblin, S. J. Smerdon and L. C. Cantley: The structural basis for 14-3-3: phosphopeptide binding specificity. Cell, 91(7), 961-71 (1997) (Pubitemid 28027829)
28. T. Boveri: Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci, 121 Suppl 1, 1-84 (2008)
29. T. Fujiwara, M. Bandi, M. Nitta, E. V. Ivanova, R. T. Bronson and D. Pellman: Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature, 437(7061), 1043-7 (2005) (Pubitemid 41486987)
30. T. W. Corson and B. L. Gallie: KIF14 mRNA expression is a predictor of grade and outcome in breast cancer. Int J Cancer, 119(5), 1088-94 (2006) (Pubitemid 44116918)
31. G. Roversi, R. Pfundt, R. F. Moroni, I. Magnani, S. van Reijmersdal, B. Pollo, H. Straatman, L. Larizza and E. F. Schoenmakers: Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Oncogene, 25(10), 1571-83 (2006) (Pubitemid 43361942)
32. K. Strebhardt and A. Ullrich: Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer, 6(4), 321-30 (2006)
33. M. Fabbro, B. B. Zhou, M. Takahashi, B. Sarcevic, P. Lal, M. E. Graham, B. G. Gabrielli, P. J. Robinson, E. A. Nigg, Y. Ono and K. K. Khanna: Cdk1/Erk2-and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell, 9(4), 477-88 (2005) (Pubitemid 41430731)
34. Y. Degenhardt and T. Lampkin: Targeting Polo-like kinase in cancer therapy. Clin Cancer Res, 16(2), 384-9 (2010)
35. J. Gautier, M. J. Solomon, R. N. Booher, J. F. Bazan and M. W. Kirschner: cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell, 67(1), 197-211 (1991) (Pubitemid 121001436)
36. H. Hermeking, C. Lengauer, K. Polyak, T. C. He, L. Zhang, S. Thiagalingam, K. W. Kinzler and B. Vogelstein: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell, 1(1), 3-11 (1997) (Pubitemid 127376388)
37. M. S. Chen, C. E. Ryan and H. Piwnica-Worms: Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol, 23(21), 7488-97 (2003) (Pubitemid 37271450)
38. C. Norbury, J. Blow and P. Nurse: Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J, 10(11), 3321-9 (1991) (Pubitemid 21905357)
39. M. E. Douglas, T. Davies, N. Joseph and M. Mishima: Aurora B and 14-3-3 coordinately regulate clustering of centralspindlin during cytokinesis. Curr Biol, 20(10), 927-33 (2010)